Supernus Pharmaceuticals, Inc. (SUPN)
29.46
-12.46
(-29.72%)
USD |
NASDAQ |
Nov 03, 14:23
Supernus Pharmaceuticals Cash and Short Term Investments (Quarterly) : 359.46M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 359.46M |
| June 30, 2026 | 372.07M |
| March 31, 2026 | 384.24M |
| December 31, 2025 | 308.67M |
| September 30, 2025 | 281.16M |
| June 30, 2025 | 522.60M |
| March 31, 2025 | 463.59M |
| December 31, 2024 | 453.61M |
| September 30, 2024 | 403.21M |
| June 30, 2024 | 347.19M |
| March 31, 2024 | 297.74M |
| December 31, 2023 | 254.87M |
| September 30, 2023 | 200.19M |
| June 30, 2023 | 151.66M |
| March 31, 2023 | 632.33M |
| December 31, 2022 | 461.33M |
| September 30, 2022 | 391.79M |
| June 30, 2022 | 360.79M |
| March 31, 2022 | 312.20M |
| December 31, 2021 | 339.68M |
| September 30, 2021 | 443.85M |
| June 30, 2021 | 409.84M |
| March 31, 2021 | 391.10M |
| December 31, 2020 | 422.53M |
| September 30, 2020 | 351.95M |
| Date | Value |
|---|---|
| June 30, 2020 | 374.81M |
| March 31, 2020 | 400.87M |
| December 31, 2019 | 347.07M |
| September 30, 2019 | 296.70M |
| June 30, 2019 | 258.57M |
| March 31, 2019 | 292.94M |
| December 31, 2018 | 356.02M |
| September 30, 2018 | 280.22M |
| June 30, 2018 | 174.41M |
| March 31, 2018 | 489.72M |
| December 31, 2017 | 140.04M |
| September 30, 2017 | 114.55M |
| June 30, 2017 | 92.97M |
| March 31, 2017 | 87.13M |
| December 31, 2016 | 90.12M |
| September 30, 2016 | 80.33M |
| June 30, 2016 | 60.21M |
| March 31, 2016 | 45.26M |
| December 31, 2015 | 62.19M |
| September 30, 2015 | 57.70M |
| June 30, 2015 | 69.79M |
| March 31, 2015 | 64.84M |
| December 31, 2014 | 74.34M |
| September 30, 2014 | 72.56M |
| June 30, 2014 | 47.27M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 305.00M |
| ANI Pharmaceuticals, Inc. | 375.87M |
| Prestige Consumer Healthcare, Inc. | 89.13M |
| Bristol Myers Squibb Co. | 12.58B |
| Liquidia Corp. | 284.18M |